Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about Context Therapeutics
Recent news which mentions Context Therapeutics
Context Therapeutics CEO Marty Lehr notes progress towards the clinic with CTIM-76 in 2Q update
August 10, 2023
Tickers
CNTX
Tags
Context Therapeutics
XNAS:CNTX
From
TheNewswire.com - RSS (Media)
Context Therapeutics shares #ASCO23 data on CLDN-6 targeted treatments and CTIM-76 update
June 13, 2023
Tags
XNAS:CNTX
Context Therapeutics
From
TheNewswire.com - RSS (Media)
ASCO 2023 – Claudin 6 Makes A Splash In Ovarian Cancer
June 08, 2023
Tickers
AMGN
BNTX
CNTX
Tags
Biotech
Partner Content
Market News
From
Benzinga
Context Therapeutics CTIM-76 bispecific antibody preclinical data presented at AACR Annual Meeting
April 24, 2023
Tags
Context Therapeutics
XNAS:CNTX
From
TheNewswire.com - RSS (Media)
Significant Unmet Need In Solid Tumors Reported, And How Context Therapeutics (NASDAQ: CNTX) Plans To Make A Difference
April 14, 2023
Tickers
CNTX
Tags
Market News
Partner Content
Biotech
From
Benzinga
Lab Notes: Center for Breakthrough Medicines expands offerings; Researchers identify key 'gene signature'
February 10, 2023
Tickers
INNO
Tags
Andrew Kossenkov
Martin Lehr
Context Therapeutics
From
Business Journals
Lab Notes: Baudax Bio completes $5M stock sale; Incyte licenses skin disease therapy
December 09, 2022
Tickers
INNO
Tags
NRX Pharmaceuticals Inc/
Insurance
NexGel
From
Business Journals
Context Therapeutics announces bispecific antibody clinical candidate to treat CLDN6+ cancers
December 06, 2022
Tags
XNAS:CNTX
Context Therapeutics
From
TheNewswire.com - RSS (Media)
Context Therapeutics Partners With Integral Molecular To Develop An Emerging Cancer Drug
November 10, 2022
Tickers
CNTX
Tags
General
Context Therapeutics
CNTX
From
Benzinga
New Ammo In The Battle Against Cancer – Context Therapeutics Sees Promising Results For Several Novel Drugs
August 17, 2022
Tickers
CNTX
Tags
Benzinga
General
Context Therapeutics
From
Benzinga
Lab Notes: Wistar Institute gets $5M NCI grant extension; Aclaris expands management team
August 05, 2022
Tickers
INNO
Tags
Context Therapeutics
Tabula Rasa HealthCare Inc/
Neal Walker
From
Business Journals
Lab Notes: Oncora Medical doubles its client base; Context Therapeutics posts promising cancer drug data
April 15, 2022
Tickers
INNO
Tags
Inno
Biotech
Kelly Beck
From
Business Journals
What About Women? This Company Targets Female-Focused Cancers
January 31, 2022
Tickers
CNTX
Tags
Market News
Partner Content
Biotech
From
Benzinga
Context Therapeutics raises $31M in fresh funding from stock sale
December 07, 2021
Tags
Insurance
Pharmaceuticals
Felix Kim
From
Business Journals
Lab Notes: CHOP-based brain tumor network gets NIH boost; Integral Molecular inks deal with Astrazeneca
November 05, 2021
Tickers
INNO
Tags
Health Care
Children's Hospital of Philadelphia
Benjamin Doranz
From
Business Journals
Lab Notes: Trice gets FDA approval for device; Ocugen files to begin Covid-19 vaccine trial
October 29, 2021
Tickers
INNO
Tags
Insurance
OptiNose Inc/
Health Care
From
Business Journals
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.